Showing 1 - 2 results of 2 for search 'Miriam Alaimo', query time: 0.01s Refine Results
  1. 1
    Safety profiles of the new target therapies—pemigatinib, futibatinib, and ivosidenib—for the treatment of cholangiocarcinoma: a systematic review

    Safety profiles of the new target therapies—pemigatinib, futibatinib, and ivosidenib—for the treatment of cholangiocarcinoma: a systematic review by Giulia Matranga, Anna Carollo, Miriam Alaimo, Sofia Cutaia, Sergio Rizzo, Alessio Provenzani

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Real-world insights into safety, tolerability, and predictive factors of adverse drug reactions in treating idiopathic pulmonary fibrosis with pirfenidone and nintedanib

    Real-world insights into safety, tolerability, and predictive factors of adverse drug reactions in treating idiopathic pulmonary fibrosis with pirfenidone and nintedanib by Alessio Provenzani, Daniele Leonardi Vinci, Miriam Alaimo, Salvatore Di Maria, Fabio Tuzzolino, Gaetano Floridia, Roberta Di Stefano, Anna Carollo, Adriana Callari, Piera Polidori, Patrizio Vitulo

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: